Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2010
10/26/2010US7820632 For inhibiting expression of human immunodeficiency virus (HIV); for use in vitro/vivo
10/26/2010US7820622 based human tetranectin C-type lectin like domains; rheumatoid arthritis, psoriasis or Crohn's disease; vectors, host cell, bioassay
10/26/2010US7820442 expression of AID in Escherichia coli gives a mutator phenotype yielding DNA nucleotide transitions at dG/dC; mutation frequency is enhanced by deficiency in uracil-DNA glycosylase indicating that AID acts by deaminating dC residues in DNA
10/26/2010US7820424 Modified hydrolase for use as template for inverse polymerase chain reaction
10/26/2010US7820421 Ketoreductases and uses thereof
10/26/2010US7820413 Incrementally truncated nucleic acids and methods of making same
10/26/2010US7820407 Heterologous proteins for use in enhancement of food products and pharmaceuticals; genetically modified Thraustochytriales microorganism for producing short chain fatty acids by a biosynthetic process
10/26/2010US7820392 for detecting the presence of the transgene/genomic insertion region; for transgenic glyphosate tolerance; genetic engineering
10/26/2010US7820391 Baseless nucleotide analogues and uses thereof
10/26/2010US7820389 Enhancing efficiency between competitor nucleic acid containing two universal bases and capture probes; sensitivity at low concentrations of amplicons
10/26/2010US7820383 utilizes interleukin allelic sequences and variable numbers of tandem repeats to diagnose and prognose cardiovascular disorders; determining a subject's predisposition to increased risk for myocardial infarction
10/26/2010US7820380 determining whether a hepatitis C virus-infected human has an increased risk for developing liver fibrosis, comprising testing nucleic acid from the human for a polymorphism in gene TLR4 as represented by position 101 of SEQ ID NO: 18973 or its complement
10/26/2010US7820162 Methods for chemically synthesizing immunoglobulin chimeric proteins
10/26/2010CA2197717C Mycobacteria functional screening and/or expression vectors
10/26/2010CA2135591C Stabilized oligonucleotides and their use
10/21/2010WO2010121009A1 Inha promoters
10/21/2010WO2010120946A1 Improvements in mass spectrum-based identification and quantitation of proteins and peptides
10/21/2010WO2010120861A1 Methods of treating cancers with her3 antisense oligonucleotides
10/21/2010WO2010120820A1 Compositions and methods for modulation of smn2 splicing
10/21/2010WO2010120374A2 Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof
10/21/2010WO2010120262A1 Methods and compositions for the treatment of medical conditions involving cellular programming
10/21/2010WO2010118477A1 Plant promoter operable in endosperm and uses thereof
10/21/2010WO2010099378A3 Assay for detection of human parvovirus nucleic acid
10/21/2010WO2010062775A3 Methods for detecting modification resistant nucleic acids
10/21/2010WO2010054004A3 Nucleic acid extraction on curved glass surfaces
10/21/2010US20100269230 Nucleic acid molecules and other molecules associated with plants
10/21/2010US20100269228 Yield enhancement in plants by modulation of a maize transcription coactivator p15 (pc4) protein
10/21/2010US20100269227 Tissue specific promoters
10/21/2010US20100269226 Tissue specific promoters
10/21/2010US20100269225 Tissue specific promoters
10/21/2010US20100269223 Dig-3 insecticidal cry toxins
10/21/2010US20100269222 Root active promoters, and uses thereof
10/21/2010US20100269221 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity
10/21/2010US20100269214 Nucleic Acid Molecules and Other Molecules Associated with Transcription in Plants and Uses Thereof for Plant Improvement
10/21/2010US20100269213 Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
10/21/2010US20100269184 Apo-2DcR
10/21/2010US20100269183 Micro-rnas that control myosin expression and myofiber identity
10/21/2010US20100269182 Lexa-based chemical-inducible gene expression system for use in transgenic animals
10/21/2010US20100269181 Method for Identifying and Managing Livestock by Genotype
10/21/2010US20100268478 Sequencing Nucleic Acid Polymers with Electron Microscopy
10/21/2010US20100267999 Extraction of solubles and microbial growth stimulants from lignocellulosic biomass and methods related thereto
10/21/2010US20100267941 Irna agents with biocleavable tethers
10/21/2010US20100267937 Cyanine Dye Labelling Reagents
10/21/2010US20100267929 PRRS Viruses, Infectious Clones, Mutants Thereof, and Methods of Use
10/21/2010US20100267927 Structure of the Insulin Receptor Ectodomain
10/21/2010US20100267816 Human anti-amyloid beta peptide antibody and fragment of said antibody
10/21/2010US20100267815 PFKFB4 Inhibitors And Methods Of Using The Same
10/21/2010US20100267813 Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs
10/21/2010US20100267811 RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS
10/21/2010US20100267810 Methods and compositions for treating neurological disease
10/21/2010US20100267809 Double stranded nucleic acid targeting low copy promoter-specific rna
10/21/2010US20100267808 Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same
10/21/2010US20100267802 Delivery method
10/21/2010US20100267649 Vascular adhesion molecules and modulation of their function
10/21/2010US20100267648 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/21/2010US20100267646 Trophic Factor for the Treatment of Retinal Degenerative Diseases
10/21/2010US20100267623 Peptides with capacity to bind to scurfin and applications
10/21/2010US20100267587 siRNA targeting cyclin dependent kinase 11 (CDK11)
10/21/2010US20100267586 siRNA targeting KRAS
10/21/2010US20100267572 Space efficient polymer sets
10/21/2010US20100267152 Sequencing Nucleic Acid Polymers with Electron Microscopy
10/21/2010US20100267145 Immunocompetent cell having anti-cd38 antibody on its cell surface
10/21/2010US20100267129 Chimeric nucleic acids encoding polypeptides comprising domains of tnf family ligands
10/21/2010US20100267128 Compositions and method for use in isolation of nucleic acid molecules
10/21/2010US20100267115 Production of 3-hydroxypropionic acid using beta-alanine/pyruvate aminotransferase
10/21/2010US20100267114 Glucoamylase Variants with Altered Properties
10/21/2010US20100267111 Polypeptide having hadh dependent hmf reductase activity
10/21/2010US20100267110 Laccases, nucleic acids encoding them and methods for making and using them
10/21/2010US20100267099 Delta-8 desaturases and their use in making polyunsaturated fatty acids
10/21/2010US20100267098 Delta-9 elongases and their use in making polyunsaturated fatty acids
10/21/2010US20100267089 Endoglucanases
10/21/2010US20100267088 Inha promoters
10/21/2010US20100267086 Optimized Nucleic Acid Sequences For The Expression of VB4-845
10/21/2010US20100267083 Modified Cytochrome P450 Monooxygenases
10/21/2010US20100267082 Novel peptide-forming enzyme gene
10/21/2010US20100267072 Formation/Elongation of Axon by Inhibiting the Expression or Function of Singar and Application to Nerve Regeneration
10/21/2010US20100267056 Differential labelling method
10/21/2010US20100267045 Cudr as biomarker for cancer progression and therapeutic response
10/21/2010US20100267038 Polynucleotides for the amplification and detection of chlamydia trachomatis and neisseria gonorrhoeae
10/21/2010US20100267033 Methods and Compositions For Detecting Autoimmune Disorders
10/21/2010US20100267024 Mutations in the macrophage scavenger receptor 1 gene alter risk of prostate cancer, asthma, and cardiovascular disease
10/21/2010US20100267023 Selective restriction fragment amplification: fingerprinting
10/21/2010US20100267022 Monocyte-derived nucleic acids and related compositions and methods
10/21/2010US20100267020 Genetic risk factor for neurodegenerative disease
10/21/2010US20100267019 Identification And Use Of Genes Encoding Amatoxin And Phallotoxin
10/21/2010US20100267018 Oligonucleotide analogues
10/21/2010US20100267014 Method for Prognosis of a Response to a Treatment
10/21/2010US20100267012 Highly conserved genes and their use to generate probes and primers for detection of microorganisms
10/21/2010US20100267004 Method, Substances and Kits for Labeling Population of RNA and Other Substances Containing Vicinal Diols
10/21/2010US20100266721 Debaryomyces castellii phytase
10/21/2010US20100266686 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases
10/21/2010US20100266677 Nucleic acid binding compounds and methods of use
10/21/2010US20100266673 Compositions and methods for the delivery of nitric oxide
10/21/2010US20100266639 Expression system
10/21/2010US20100266618 Compositions and methods for augmenting activity of oncolytic viruses
10/21/2010US20100266617 Antibodies to human programmed death receptor pd-1
10/21/2010US20100266616 Polypeptides, antibody variable domains and antagonists
10/21/2010US20100266613 Anti-tnf-alpha antibodies and their uses
10/21/2010US20100266612 Bmp-alk3 antagonists and uses for promoting bone growth
10/21/2010US20100266609 Antibody Molecules Which Bind IL-17A and IL-17F
1 ... 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 ... 899